Atara Biotherapeutics, Inc.

Summary

Atara Biotherapeutics, Inc. is a business^[1]. Atara Biotherapeutics, Inc. is known by 3 alternative names across languages and contexts.^[2]

Key Facts

• Atara Biotherapeutics, Inc.'s field of work was post-transplant lymphoproliferative disorder^[3].
• Atara Biotherapeutics, Inc.'s field of work was immunotherapy^[4].
• Atara Biotherapeutics, Inc.'s field of work was T-lymphocytes^[5].
• Atara Biotherapeutics, Inc.'s field of work was Epstein–Barr virus^[6].
• Atara Biotherapeutics, Inc. is in the country of United States^[7].
• Atara Biotherapeutics, Inc. is in the country of US^[8].
• Atara Biotherapeutics, Inc.'s instance of is recorded as business^[9].
• Atara Biotherapeutics, Inc.'s instance of is recorded as enterprise^[10].
• Atara Biotherapeutics, Inc.'s instance of is recorded as public company^[11].
• Atara Biotherapeutics, Inc.'s headquarters location is recorded as South San Francisco^[12].
• Atara Biotherapeutics, Inc. is part of NASDAQ Biotechnology Index^[13].
• Atara Biotherapeutics, Inc. is part of Russell 2000^[14].
• Atara Biotherapeutics, Inc.'s stock exchange is recorded as Nasdaq^[15].
• Atara Biotherapeutics, Inc.'s industry is recorded as biotechnology^[16].
• Atara Biotherapeutics, Inc.'s industry is recorded as oncology^[17].
• Atara Biotherapeutics, Inc.'s industry is recorded as multiple sclerosis^[18].
• Atara Biotherapeutics, Inc.'s industry is recorded as autoimmune disease^[19].
• Atara Biotherapeutics, Inc.'s industry is recorded as Cellular therapy and transplantation^[20].
• 2012 marks the founding of Atara Biotherapeutics, Inc.^[21].
• Atara Biotherapeutics, Inc.'s official website is recorded as http://www.atarabio.com/^[22].
• Atara Biotherapeutics, Inc.'s legal form is recorded as Delaware corporation^[23].
• Atara Biotherapeutics, Inc.'s legal form is recorded as XTIQ^[24].

Product Details

The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.

GLEIF Golden Copy — Level 1 entity data

• Legal Entity Identifier (LEI): 549300WBXUXZRE03MS38^[25]

• Registered legal name: Atara Biotherapeutics, Inc.^[26]

• Legal jurisdiction: US-DE^[27]

• GLEIF entity category: GENERAL^[28]

• Legal form (ISO 20275 ELF): XTIQ^[29]

• Entity status: ACTIVE^[30]

• LEI registration status: LAPSED^[31]

• LEI first registered: 2014-06-26^[32]

• LEI last updated: 2023-08-04^[33]

• LEI next renewal: 2015-06-24^[34]

• Managing LOU: 5493001KJTIIGC8Y1R12^[35]

• Registration authority: RA000602^[36]

• Authority entity ID: 5202188^[37]

• Conformity flag: NON_CONFORMING^[38]

Body

Founding

2012 marks the founding of Atara Biotherapeutics, Inc.^[21].

Identity

Part of include NASDAQ Biotechnology Index^[13], a stock market index^[39], in United States^[40] and Russell 2000^[14], a stock market index^[41].

Operations

Atara Biotherapeutics, Inc.'s headquarters location is recorded as South San Francisco^[12].

Industry

Industries include biotechnology^[16], oncology^[17], multiple sclerosis^[18], autoimmune disease^[19], and Cellular therapy and transplantation^[20]. Fields of work include post-transplant lymphoproliferative disorder^[3], a class of disease^[42]; immunotherapy^[4], a type of medical treatment^[43]; T-lymphocytes^[5], a cell type^[44]; and Epstein–Barr virus^[6], a taxon^[45].

Ownership

Atara Biotherapeutics, Inc.'s stock exchange is recorded as Nasdaq^[15].

Why It Matters

Atara Biotherapeutics, Inc. is known by 3 alternative names across languages and contexts.^[2]